1Spatzenegger M,Jaeger W.Clinical importance of hepatic cytochrome P450 in drug metabolism[J].Drug Metab Rev,1995,27(3):397-417.
2Zhou S,Yung Chan S,Chef Goh B,et al.Mechanism-based inhibition of cytochrome P450 CYP3A4 by therapeutic drugs[J].Clin Pharmacokinet,2005,44(3):279-304.
3Korbonen T,Tolonen A,Unsitalo J,et al.The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel[J].Br J Clin Pharmacol,2005,60(1):69-75.
4Zebrowska L,Saymczyk G,Wrobel A.Adverse effects of interactions of antibiotics with other drugs[J].Pol Merkur Lekarski,2000,9(51):623-626.
5Zhang H,Wang B,Cui D,et al.Pharmacokinetic drug interactions involving 17-alpha-ethinylestradiol:a new look at an old drug[J].Clin Pharmacokinet,2007,46(2):133-135.
6Van Dijke CP,Weber JC.Interaction between oral contraceptives and griseofulvin[J].Br Med J(Clin Res Ed),1984,288(6424):1125-1126.
7Grauford PM.Managing epilepsy in women of childbearing age[J].Drug Saf,2009,32(4):293-307.
8Grauford PM.Best practice guidelines for the management of women with epilepsy[J].Epilepsia,2005,46(9):117-124.
9Vrzal R,Kubesova K,Pavek P,et al.Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4:investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines[J].Toxicol Lett,2010,193(2):183-188.
10Burakgazi E,Harden C,Kelly JJ.Contraception for women with epilepsy[J].Rev Neurol Dis,2009,6(2):62-67.
